Carloni, Paolo
 Distribuzione geografica
Continente #
EU - Europa 1.571
NA - Nord America 1.176
AS - Asia 478
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 1
Totale 3.233
Nazione #
US - Stati Uniti d'America 1.146
RU - Federazione Russa 713
CN - Cina 229
IE - Irlanda 210
SE - Svezia 202
IT - Italia 149
SG - Singapore 98
UA - Ucraina 98
TR - Turchia 79
GB - Regno Unito 54
DE - Germania 48
HK - Hong Kong 45
CA - Canada 30
FI - Finlandia 24
BE - Belgio 17
FR - Francia 17
GR - Grecia 8
CH - Svizzera 7
EU - Europa 7
VN - Vietnam 7
LB - Libano 5
NL - Olanda 5
CZ - Repubblica Ceca 4
PL - Polonia 4
RO - Romania 4
UZ - Uzbekistan 4
AT - Austria 3
IN - India 3
ES - Italia 2
JP - Giappone 2
MN - Mongolia 2
BD - Bangladesh 1
HR - Croazia 1
KE - Kenya 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 3.233
Città #
Chandler 231
Dublin 210
Ann Arbor 154
Moscow 130
Jacksonville 125
Boardman 72
Scuola 71
Izmir 62
New York 58
Singapore 57
Nanjing 56
Saint Petersburg 53
Ashburn 51
Hong Kong 45
Wilmington 44
Woodbridge 44
Dearborn 39
Santa Clara 31
Toronto 30
Beijing 24
Princeton 21
Ogden 18
Brussels 17
Istanbul 17
Brooklyn 16
Pisa 16
Kunming 13
Nanchang 12
Hebei 11
Helsinki 11
Milan 11
Houston 10
Shenyang 9
Tianjin 9
Washington 8
Dong Ket 7
Hangzhou 6
Seattle 6
Falls Church 5
Frankfurt Am Main 5
Trieste 5
Bologna 4
Leiden 4
Ningbo 4
Orange 4
Shanghai 4
Zhengzhou 4
Auburn Hills 3
Florence 3
Jiaxing 3
Jinan 3
Lausanne 3
Los Angeles 3
Palermo 3
Rietberg 3
Thessaloniki 3
Timisoara 3
Bari 2
Candelo 2
Dongguan 2
Duncan 2
Fribourg 2
Fuzhou 2
Genova 2
Hefei 2
Krakow 2
Lanzhou 2
Las Vegas 2
Pontedera 2
Pordenone 2
Pozuelo del Rey 2
Redwood City 2
Rome 2
Aachen 1
Athens 1
Berlin 1
Changchun 1
Changsha 1
Council Bluffs 1
Des Moines 1
Dhaka 1
Fairfield 1
Genoa 1
Guangzhou 1
Hanover 1
Hyderabad 1
Indiana 1
Jinhua 1
Jülich 1
Landsberg 1
Luxembourg 1
Manila 1
Mumbai 1
Mönchengladbach 1
Nairobi 1
Naples 1
Newark 1
North Bergen 1
Norwalk 1
Olomouc 1
Totale 1.933
Nome #
Serpin inhibitors for the treatment of prion and prion-like diseases 195
Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules 187
Permeability Coefficients of Lipophilic Compounds Estimated by Computer Simulations 172
Ionic charge transfer effects in water, channels and enzymes 169
Anthrax Lethal Factor Investigated by Molecular Simulations 166
Classical and quantum chemical studies of copper phenanthroline complexes binding the DNA 165
Parameterization of novel anticancer drugs via a QM/MM force matching procedure and effect of drug-binding on DNA flexibility 159
Unifying view of mechanical and functional hotspots across class A GPCRs 159
Role of protein frame and solvent for the redox properties of azurin from Pseudomonas aeruginosa 153
Second step of hydrolytic dehalogenation in haloalkane dehalogenase investigated by QM/MM methods 150
Huntingtin: Stability and Interaction with Molecular Partner from Computational Biophysics Studies 146
Computational Study of the DNA-Binding Protein Helicobacter pylori NikR: The Role of Ni2+ 145
Protonation state and substrate binding to B2 metallo-beta-lactamase CphA from Aeromonas hydrofila 145
Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras 144
Understanding anticancer Drug-DNA interactions via molecular dynamics simulations 143
Huntigton disease: Cooperative hydrogen bonding in polyQ aggregates 143
Nitrogen fixation by a biologically-inspired catalyst: An ab initio and hybrid qm/mm molecular dynamics study 142
Structural facets of disease-linked human prion protein mutants: A molecular dynamic study 141
The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations 141
Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 124
Water and potassium dynamics inside the KcsA K+ channel 119
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance 60
Erratum: Discovery of a class of diketopiperazines as antiprion compounds 52
Erratum: Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 50
Totale 3.370
Categoria #
all - tutte 12.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 0 29 31 72 30 23 32 25 4
2020/2021242 32 3 1 27 4 47 25 2 26 27 16 32
2021/2022264 32 24 1 45 35 6 17 18 7 11 24 44
2022/2023573 72 80 54 66 17 121 63 21 58 4 8 9
2023/2024447 15 3 18 9 60 203 22 13 53 13 8 30
2024/2025853 164 61 101 342 185 0 0 0 0 0 0 0
Totale 3.370